Advertisement

Topics

Cowen Healthcare Royalty Partners Company Profile

02:44 EST 23rd November 2017 | BioPortfolio

Cowen Healthcare Royalty Partners is a global healthcare private equity firm that invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purchase of royalty interests. The investment team has over 100 years of healthcare related experience including principal investing, structured finance, healthcare industry senior management, Wall Street research and consulting, scientific and clinical experience. For more information, visit www.cowenroyalty.com.


News Articles [656 Associated News Articles listed on BioPortfolio]

ImmunoMet Therapeutics Promotes Benjamin Cowen to CEO

Benjamin Cowen, chief operating officer of ImmunoMet Therapeutics, is taking on a new role as CEO of the Houston-based drug developer. Founder and former CEO Sung-Wuk Kim will continue to serve as cha...

Kevin Raidy Named Managing Partner of Cowen Healthcare Investments

Strategy Focused on Investing in Mid-to-Late Stage Private Healthcare Companies Newly Established Investment Platform Expands Cowen’s Leading Position in Healthc...

Cowen assesses Amazon's Rx potential, marks RAD as prime acquisition target

David SalazarNew York-based equity research firm Cowen has sized up the threat Amazon poses to the industry, and while its entry would not be as disruptive as some might think, there are still opportu...

Atul Gawande on AI

Tyler Cowen has one of his “Conversations” with Atul Gawande.  The interview is interesting throughout.  Below is an excerpt from their discussion on artificial intelligence. TYLER COW...

Impax Laboratories, Inc. (IPXL) Rating Reiterated by Cowen and Company

's stock had its "hold" rating restated by equities research analysts at Cowen and Company in a report issued on Friday. They presently have a $16.00 price target on the specialty pharmaceutical c...

George Millstien, Managing Director, Cowen

In this episode of PharmaTelevision News Review, filmed at AusBio 2012 in Melbourne, Australia, Fintan Walton talks to George Millstien, Managing Director at Cowen

Edwards Lifesciences Corporation (EW) Earns "Buy" Rating from Cowen and Company

's stock had its "buy" rating reissued by stock analysts at Cowen and Company in a research report issued to clients and investors on Thursday. They currently have a $135.00 target price on the me...

Vertex Pharmaceuticals-Aktie: Preiserhöhung gibt Vertrauen! - Aktienanalyse

New York - Vertex Pharmaceuticals-Aktienanalyse von Analyst Philip Nadeau von Cowen and Company: Phil Nadeau, Aktienanalyst von Cowen and Company, rechnet laut einer aktuellen Aktienanalyse bei den...

Drugs and Medications [477 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [1199 Associated PubMed Articles listed on BioPortfolio]

Partners' Overestimation of Patients' Pain Severity: Relationships with Partners' Interpersonal Responses.

The present study examined whether concordance between patients' and their partners' reports of patient pain severity relates to partners' social support and behavioral responses in couples coping wit...

Invited Commentary. The Royalty of Evidence: The Randomized Control Trials.

A qualitative study of secondary distribution of HIV self-test kits by female sex workers in Kenya.

Promoting awareness of serostatus and frequent HIV testing is especially important among high risk populations such as female sex workers (FSW) and their sexual partners. HIV self-testing is an approa...

Interview With Rulon F. Stacey, PhD, FACHE, Managing Director, Healthcare, Navigant Consulting.

Practitioner Application: Ten CEO Imperatives for Healthcare Transformation: Lessons From Top-Performing Academic Medical Centers.

Clinical Trials [1064 Associated Clinical Trials listed on BioPortfolio]

Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.

Specific Aim: To conduct a randomized controlled trial among permanent employees of Partners HealthCare, Inc., and their adult dependents, who are current tobacco smokers. The trial will c...

Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography

This proposal is based on findings from our previous work involving ferumoxytol-enhanced cardiac magnetic resonance angiography. The resolution of the pulmonary vasculature based on our pr...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

To Develop a Validated Program and Use it to Evaluate Patients Post-operatively

Annually, the Department of Anesthesiology, Siriraj hospital has responsibilities to take care of more than 50,000 patients peri-operatively. According to Maslow's hierarchy of needs; huma...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Companies [2752 Associated Companies listed on BioPortfolio]

Cowen Healthcare Royalty Partners

Cowen Healthcare Royalty Partners is a global healthcare private equity firm that invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purch...

HealthCare Royalty Partners

HealthCare Royalty Partners (HCRP) is a global healthcare investment firm focused on investing primarily in commercial stage healthcare product assets. HCRP manages over $3 billio...

Cowen Group, Inc.

Cowen Group, Inc. is a leading diversified financial services firm providing alternative investment management, investment banking, research, and sales and trading services through its business units,...

DRUG ROYALTY CORPORATION INC

A pioneer in the field when launched in 1992, Drug Royalty was the first firm to provide royalty-based financing in the life sciences sector and the first to complete royalty transactions with invento...

Capital Royalty L.P.

Our diversified team of investment professionals is dedicated to meeting the specific needs of each client, and with our extensive experience in the healthcare and financial industries, Capital Royalt...

More Information about "Cowen Healthcare Royalty Partners" on BioPortfolio

We have published hundreds of Cowen Healthcare Royalty Partners news stories on BioPortfolio along with dozens of Cowen Healthcare Royalty Partners Clinical Trials and PubMed Articles about Cowen Healthcare Royalty Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cowen Healthcare Royalty Partners Companies in our database. You can also find out about relevant Cowen Healthcare Royalty Partners Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...


Corporate Database Quicklinks



Searches Linking to this Company Record